GOLDEN,
Colo.--(BUSINESS WIRE)--May 26, 2004-- Isonics Corporation
(Nasdaq:ISON), a world-wide leader in the development
of isotopically engineered semiconductor materials utilizing
advances in nanotechnology, and a supplier of silicon-on-insulator
(SOI) wafers to the semiconductor industry and isotopes
for life sciences and health care applications, announced
today that the Company is launching an initiative to
leverage its European presence and broaden its shareholder
base in the region.
The Company is listed on the Frankfurt Stock Exchange
as "IO9." The Company already has a strong
foothold in Europe through its wholly-owned subsidiary,
Chemotrade, based in Dusseldorf, Germany. Chemotrade
is a value-added re-seller of stable and radioactive
isotopes for pharmaceutical and industrial research
as well as for industrial and medical imaging, calibration
sources and for brachytherapy applications in the European
market. In addition, Isonics has a 6% interest in Berlin-based
Institut of Umwelttechnologien GmbH (IUT). As part of
the Company's commitment to Homeland Security, Isonics
and IUT have formed a US-based subsidiary IUTDetection
Technologies, Inc. to commercialize IUT's neutron-based
detection technology that can be used to detect explosives,
chemical and biological weapons. When products using
this technology are developed, the Company will seek
to capitalize on the burgeoning Homeland Security market.
Commenting on the pending campaign to expand awareness
in Europe, James E. Alexander, Isonics' president and
CEO said, "In today's somewhat volatile markets,
it obviously helps to have as broad a shareholder base
as possible, and we feel that we have a strong story
to tell to the European investment community. We plan
to use our existing presence as a springboard for several
initiatives over the coming months to let foreign investors
know who we are and what we do. Also, with recent tragic
terrorist attacks in Europe, the fact that we are focused
on developing products for explosive detection is a
huge plus. We believe European investors will be very
interested in Isonics and in our portfolio of products
and technologies."
About Isonics Corporation
Isonics Corporation has three business divisions:
(1) Isonics Semiconductor, (2) Isonics Life Sciences,
and (3) Homeland Security. Isonics is a world leader
in isotopically engineered materials and through its
semiconductor division produces isotopically pure silicon-28
chemicals and wafers for the semiconductor industry.
Through advances in nanotechnology, the Company is also
focused on research and development opportunities for
further, value-added product and application development.
Isonics' Life Sciences division markets and sells stable
isotopes for the health care industry such as carbon-13
for diagnostic breath tests and drug design, and radioisotopes
and stable isotopes, such as oxygen-18 for positron
emission tomography (PET) imaging. Stable isotopes can
be thought of as ultra pure materials. This high degree
of purification provides enhanced properties as compared
to natural materials. Our efforts in the Homeland Security
segment are nascent at the present time as we proceed
to develop further our neutron-based detection technology.
Additional
information may be obtained at the Company's Web site
at http://www.isonics.com.
|
